Heparan sulfate staining of the glomerular basement membrane in relation to circulating anti-DNA and anti-heparan sulfate reactivity: A longitudinal study in NZB/W F1 mice

Journal of Autoimmunity

Volumn 9, Issue 1, 1996, Pages 41-50

  Hylkema, Machteld N ^a   Van Bruggen, Mieke C J ^b   Van De Lagemaat, Ruud ^a   Kramers, Kees ^b   Berden, Jo H M ^b   Smeenk, Ruud J T ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anti DNA; Heparan sulfate; Nefritis; NZB W mice

Indexed keywords

AUTOANTIBODY; DNA ANTIBODY; ENDOGENOUS COMPOUND; HEPARAN SULFATE;

ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETIOLOGY; FEMALE; GLOMERULUS BASEMENT MEMBRANE; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN DEPOSITION; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029985566     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0006     Document Type: Article

References (39)

1. Koffler D., Agnello V., Thoburn R., Kunkel H.G. 1971. Systemic Lupus Erythematosus: prototype of immune complex nephritis in man. J. Exp. Med. 134: 169S-179S
2. Izui S., Lambert P.H., Miescher P.A. 1976. In vitro demonstration of a particular affinity of glomerular basement membrane and collagen: a possible basis for a local formation of DNA/anti-DNA complexes in Systemic Lupus Erythematosus. J. Exp. Med. 144: 428-441
3. Mannik M. 1992. Immune complexes. In Systemic Lupus Erythematosus. R.G. Lahita, ed. John Wiley, New York. pp. 327-341
4. Raz E., Brezis M., Rosenmann E., Eilat D. 1989. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J. Immunol. 142: 3076-3082
5. Couser W.G., Salant D.J. 1980. In situ immune complex formation and glomerular injury. Kidney Int. 17: 1-13
6. Mohan C., Adams S., Stanik V., Datta S.K. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177: 1367-1381
7. Fournié G.J. 1988. Circulating DNA and lupus nephritis. Kidney Int. 33: 487-497
8. Rumore P.M., Steinman C.R. 1990. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J. Clin. Invest. 86: 69-74
9. Burlingame R.W., Rubin R.L., Balderas R.S., Theofilopoulos A.N. 1993. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J. Clin. Invest. 91: 1687-1696
10. Schmiedeke T.M.J., Stöckl F.W., Weber R., Sugisaki Y., Batsford S.R., Vogt A. 1989. Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis. J. Exp. Med. 169: 1879-1894
11. Termaat R.M., Assmann K.J.M., Dijkman H.B.P.M., Van Compel F., Smeenk R., Berden J.H.M. 1992. Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms. Kidney Int. 42: 1363-1371
12. Kramers C., Hylkema M.N., Van Bruggen M.C.J., Van de Lagemaat R., Dijkman H.B.P.M., Assmann K.J.M., Smeenk R.J.T., Berden J.H.M. 1994. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J. Clin. Invest. 94: 568-577
13. Brinkman K., Termaat R.-M., Berden J.H.M., Smeenk R.J.T. 1990. Anti-DNA antibodies and lupus nephritis: the complexity of crossreactivity. Immunol. Today 11: 232-234
14. Kramers C., Hylkema M.N., Termaat R.-M., Brinkman K., Smeenk R.J.T., Berden J.H.M. 1993. Histones in lupus nephritis. Exp. Nephrol. 1: 224-228
15. Eilat D. 1986. Cross-reactions of anti-DNA antibodies and the central dogma of lupus nephritis. Immunol. Today 6: 123-127
16. Faaber P., Rijke G.P.M., Van de Putte L.B.A., Capel P.J.A., Berden J.H.M. 1986. Crossreactivity of human and murine anti-DNA antibodies with heparan sulphate: the major glycosaminoglycan in glomerular basement membrane. J. Clin. Invest. 77: 1824-1830
17. Termaat R.M., Brinkman K., Nossent J.C., Swaak A.J.G., Smeenk R.J.T., Berden J.H.M. 1990. Anti-heparan sulphate reactivity in sera from patients with systemic lupus erythematosus with renal or non-renal manifestations. Clin. Exp. Immunol. 82: 268-274
18. Kramers C., Termaat R.M., ter Borg E.J., Van Bruggen M.C.J., Kallenberg C.G.M., Berden J.H.M. 1993. Higher anti-heparan sulphate reactivity during systemic lupus erythematosus (SLE) disease exacerbations with renal manifestations; A long term prospective analysis. Clin. Exp. Immunol. 93: 34-38
19. Neparstek Y., Ben-Yehuda A., Madaio M.P., Bar-Tana R., Schuger L., Pizov G., Neeman Z., Cohen I.R. 1990. Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRL-lpr/lpr mice by heparin. Arthritis Rheum. 33: 1554-1559
20. Termaat R.-M., Brinkman K., van Gompel F., van de Heuvel L.P.W.J., Veerkamp J.H., Smeenk R.J.T., Berden J.H.M. 1990. Crossreactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J. Autoimmunity 3: 531-538
21. Hylkema M.N., van der Zwet I., van de Lagemaat R., Kramers C., van Bruggen M.C.J., Swaak A.J.G., Berden J.H.M., Smeenk R.J.T. 1995. No evidence for an independent role of anti-heparan sulfate reactivity apart from anti-DNA in lupus nephritis. Clin. Exp. Immunol. 101: 55-65
22. Mancini G., Carbonara A.O., Heremans J.F. 1965. Immunochemical quanti-tation of antigens by single radial immunodiffusion. Immunochemistry 2: 235-254
23. van den Heuvel, L.P.W.J., van den Born J., van de Velden T.J.A.M., Veerkamp J.H., Monnens L.A.H., Schroder C.H., Berden J.H.M. 1990. Isolation and partial characterization of heparan sulfate proteoglycan from human glomerular basement membrane. Biochem. J. 264: 457-465
24. van den Born J., van den Heuvel L.P.W.J., Bakker M.A.H., Veerkamp J.H., Assman K.J.M., Weening J.J., Berden J.H.M. 1993. Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int. 43: 454-463
25. Hylkema M.N., Huygen H., Kramers C., van der Wal Th.J., de Jong J., van Bruggen M.C.J., Swaak A.J.G., Berden J.H.M., Smeenk R.J.T. 1994. Clinical evaluation of a modified ELISA, using photobiotinylated DNA, for the detection of anti-DNA antibodies. J. Immunol. Methods 170: 93-102
26. Hylkema M.N., Kramers C., Van der Wal T.J., Van Bruggen M.C.J., Swaak A.J.G., Berden J.H.M., Smeenk R.J.T. 1994. A new ELISA for the detection of anti-heparan sulfate reactivity, using photobiotinylated antigen. J. Immunol. Methods 176: 33-43
27. Kanwar Y.S., Linker A., Farquhar M.G. 1980. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulphate) by enzyme digestion. J. Cell. Biol. 86: 688
28. Deen W.M. 1982. The glomerular barrier to macromolecules: theoretical and experimental considerations. In Nephrotic Syndrome. Contemporary issues in nephrology. B. M. Brenner and J. H. Stein, eds. Churchill Livingstone, New York.
29. Vernier R.L., Klein D.J., Sisson S.P., Mahan M.D., Oegama T.R., Brown D.M. 1983. Heparan sulphate-rich anionic sites in human glomerular basement membrane: decreased concentration in congenital nephritic syndrome. N. Engl. J. Med. 309: 1001
30. Ihrcke N.S., Wrenshall L.E., Lindman B.J., Platt J.L. 1993. Role of heparan sulfate in immune system-blood vessel interactions. Immunol. Today 14: 500-505
31. Madaio M.P., Carlson J., Cataldo J., Ucci A., Migliorini P., Pankewycz O. 1987. Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J. Immunol. 138: 2883-2889
32. Suzuki N., Harada T., Mizushima Y., Sakane T. 1993. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus. J. Immunol. 151: 1128-1136
33. Tsao B.P., Ebling F.M., Roman C., Panosian-Sahakian N., Calame K., Hahn B.H. 1990. Structural characteristics of the variable regions of immunoglobulin genes encoding a pathogenic autoantibody in murine lupus. J. Clin. Invest. 85: 530-540
34. Schmiedeke T., Stoeckl F., Muller S., Sugisaki Y., Batsford S., Woitas R., Vogt A. 1992. Glomerular immune deposits in murine lupus models may contain histones. Clin. Exp. Immunol. 90: 453-458
35. Stöckl F., Muller S., Batsford S., Schmiedeke T., Waldherr R., Andrassy K., Sugisaki Y., Nakabayashi K., Nagasawa T., Rodriguez-Iturbe B., Donini U., Vogt A. 1994. A role for histones and ubiquitin in lupus nephritis. Clin. Nephrol. 41: 10-17
36. Swaak A.J.G., Aarden L.A., Statius van Eps L.W., Feltkamp T.E.W. 1979. Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum. 22: 226-235
37. Swaak A.J.G., Groenwold J., Aarden L.A., Statius van Eps L.W., Feltkamp T.E.W. 1982. Prognostic value of anti-dsDNA in SLE. Ann. Rheum. Dis. 41: 388-395
38. ter Borg E.J., Horst G., Hummel E.J., Limburg P.C., Kallenberg G.G.M. 1990. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus: A long-term, prospective study. Arthritis Rheum. 33: 634-654
39. Kashihara N., Makino H., Szekanecz Z., Waltenbaugh C.R., Kanwar YS. 1992. Nephritogenicity of anti-proteoglycan antibodies in experimental murine lupus nephritis. Lab. Invest. 67: 752-760